A #clinical stage, biopharmaceutical company developing biologics to modulate the function of #cytokines and provide therapeutic benefit to #cancerpatients.
Basel, Switzerland
Joined April 2021
- Tweets5
- Following62
- Followers30
- Likes8
Anaveon to present first clinical data from the Phase I/II study of ANV419 at the AACR Annual Meeting 2022 synconaltd.com/news-and-insi…
ANAVEON AG we are #hiringstrongcandidates. Please have a look! lnkd.in/ekbjgyxZ
ANAVEON AG is delighted to announce the conclusion of our #SeriesB financing with company-builder investors.
We are looking forward to deliver on the #therapeutic potential of our #pipeline.
#financing #innovation lnkd.in/ekYq2uAi
ANAVEON AG receives CTA approval to start a Phase I/II study to evaluate the safety, dosing and clinical activity of ANV419 in patients with solid tumors #oncologyclinicalresearch #cancer #cytokines #immunooncology #clinicaltrials